Literature DB >> 8575472

Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model.

C J van der Laken1, O C Boerman, W J Oyen, M T van de Ven, R A Claessens, J W van der Meer, F H Corstens.   

Abstract

In the present study, radioiodinated human recombinant interleukin-1 (IL-1) was investigated for its potential to image infectious foci in vivo in an animal model of infection. Twenty-four hours after induction of a Staphylococcus aureus abscess in the left calf muscle, mice were i.v. injected with both iodine-125 labelled IL-1 and iodine-131 labelled myoglobin, a size-matched control agent. The animals were killed for tissue biodistribution studies at 2, 6, 12, 24 and 48 h p.i. Gamma camera images were obtained at 6, 24 and 48 h after injecting mice with 123I-IL-1. Radioiodinated IL-1 rapidly cleared from the body; after 12 h the abscess was the organ with the highest activity. The absolute abscess uptake of 125I-IL-1 remained high compared to 131I-myoglobin, resulting in significantly higher abscess-to-muscle ratios of 125I-IL-1 compared to 131I-myoglobin. The ratios of 125I-IL-1 reached the ultimate value of 44.4+/-10.8 at 48 h p.i., whereas the ratios of 131I-myoglobin did not exceed 5.9+/-0.7. Gamma camera imaging revealed clearly visible abscesses. In conclusion, our results demonstrate specific retention of radioiodinated IL-1 in the abscess, presumably by interaction of IL-1 with its receptor on the inflammatory cells. The high target-to-background ratios that were obtained over the course of time indicate that the IL-1 receptor may be a valuable target for the imaging of infectious foci.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575472     DOI: 10.1007/bf00801608

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  19 in total

1.  Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.

Authors:  W J Oyen; R A Claessens; J M Raemaekers; B E de Pauw; J W van der Meer; F H Corstens
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

2.  Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

Authors:  T Lindmo; E Boven; F Cuttitta; J Fedorko; P A Bunn
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

3.  A point mutation uncouples human interleukin-1 beta biological activity and receptor binding.

Authors:  L Gehrke; S A Jobling; L S Paik; B McDonald; L J Rosenwasser; P E Auron
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

4.  The distribution and clearance of radiolabeled human interleukin-1 beta in mice.

Authors:  R C Newton; J Uhl; M Covington; O Back
Journal:  Lymphokine Res       Date:  1988

5.  Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit.

Authors:  J W Babich; W Graham; S A Barrow; S C Dragotakes; R G Tompkins; R H Rubin; A J Fischman
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

6.  Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans.

Authors:  E V Granowitz; R Porat; J W Mier; J P Pribble; D M Stiles; D C Bloedow; M A Catalano; S M Wolff; C A Dinarello
Journal:  Cytokine       Date:  1992-09       Impact factor: 3.861

Review 7.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

8.  Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.

Authors:  R H Zubler; F Erard; R K Lees; M Van Laer; C Mingari; L Moretta; H R MacDonald
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor.

Authors:  J W Lowenthal; H R MacDonald
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  7 in total

1.  Macrophage targeting in experimental arthritis.

Authors:  W J Oyen; O C Boerman; C J van der Laken; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1996-06

Review 2.  Radiotracers used for the scintigraphic detection of infection and inflammation.

Authors:  Chris Tsopelas
Journal:  ScientificWorldJournal       Date:  2015-02-08

Review 3.  The uptake mechanisms of inflammation- and infection-localizing agents.

Authors:  W J Oyen; O C Boerman; C J van der Laken; R A Claessens; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1996-04

4.  Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.

Authors:  C J van der Laken; O C Boerman; W J Oyen; M T van de Ven; R Chizzonite; F H Corstens; J W van der Meer
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 5.  Molecular imaging in atherosclerosis.

Authors:  Andor W J M Glaudemans; Riemer H J A Slart; Alessandro Bozzao; Elena Bonanno; Marcello Arca; Rudi A J O Dierckx; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

6.  Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection.

Authors:  C J van der Laken; O C Boerman; W J Oyen; M T van de Ven; R A Claessens; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1996-11

7.  Antimicrobial peptides as infection imaging agents: better than radiolabeled antibiotics.

Authors:  Muammad Saeed Akhtar; Muhammad Babar Imran; Muhammad Afzal Nadeem; Abubaker Shahid
Journal:  Int J Pept       Date:  2012-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.